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Vision Research 48 (2008) 1183–1185ReplyReply to Ke´ri, S. The magnocellular system and schizophreniaAbstract
Keri [Keri, S. (2008). The magnocellular pathway and schizophrenia. Vision Research, 48,1181–1182] raises concerns about the conclu-
sion of our recent review [Skottun, B. C., & Skoyles, J. R. (2007a). Contrast sensitivity and magnocellular functioning in schizophrenia.
VisionResearch, 47, 2923–2933] that contrast sensitivity data provide little evidence formagnocellular deﬁcits in schizophrenia. He also sug-
gests other lines of evidence for such deﬁcits.We respond that these concerns are unfounded, and that these other lines of evidence are weak.
 2008 Elsevier Ltd. All rights reserved.Keywords: Contrast sensitivity; Schizophrenia; Magnocellular; Vision; Sensory deﬁcitsIn our recent review (Skottun & Skoyles, 2007a), we
found little evidence for magnocellular deﬁcits in schizo-
phrenia from studies of contrast sensitivity. In response,
Keri (2008) states that ‘‘behavioral, electrophysiological
and imaging studies” point to magnocellular deﬁcits in
schizophrenia, and also raises four speciﬁc issues. As delin-
eated below, we ﬁnd that neither set of concerns requires
alteration of our conclusion.
In our view (Skottun & Skoyles, 2007b, 2008, in press-b),
many of the lines of evidence taken to suggest a magnocellu-
lar deﬁcit in schizophrenia are problematic. We mention a
few examples. One is backwardmasking. Rassovsky, Green,
Nuechterlein, Breitmeyer, and Mintz (2004) and Green,
Nuechterlein, Breitmeyer, Tsuang, and Mintz (2003) found
abnormalities under both forward and backward masking
and under both Type-A and Type-B masking, even though
it is primarily Type-B backward masking which has been
postulated to reﬂect magnocellular activity (Breitmeyer &
Ganz, 1976). Another example is electrophysiological meth-
odswhich have been reviewed elsewhere (Skottun&Skoyles,
2004, 2007b, 2007c). Also, anatomical postmortem studies
(Selemon & Begovic, 2007) have found no abnormalities in
neither the magnocellular nor parvocellular LGN layers.
Keri holds up the review of Butler and Javitt (2005). That pa-
per cited the work of Slaghuis (1998) as evidence for magno-
cellular deﬁcits. However, Slaghuis (1998) reported uniform
reductions in contrast sensitivity. This does not indicate a
magnocellular deﬁcit. Also, Butler and Javitt (2005, p.152)
stated that the magnocellular system mediates detection of0042-6989/$ - see front matter  2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.visres.2008.02.010small stimuli. This must be incorrect since the magnocellular
system is responsible for the detection of low spatial frequen-
cies, i.e. large stimuli. We now consider the four speciﬁc
concerns raised by Keri (2008).
Issue 1. Keri (2008) writes that we ‘‘overemphasize the
role of spatial frequency”, This seems to disregard our review
of temporal contrast sensitivity which is even more negative
with regard to providing evidence for magnocellular deﬁcits
than the spatial frequency studies, since no temporal studies
showed evidence for a magnocellular deﬁcit (see Fig. 3 of
Skottun & Skoyles, 2007a). (In the case of spatial contrast
sensitivity, in comparison, there was at least one study con-
sistent with a magnocellular deﬁcit.)
Keri (2008) cites evidence thatmagnocellular neurons can
display higher contrast sensitivity than parvocellular neu-
rons at 9 c/deg. We agree that the exact crossover point
above which contrast sensitivity is dominated by the parvo-
cellular system can depend on experimental conditions (see
Skottun & Skoyles, 2007a, p. 2925 for a discussion). How-
ever, irrespective of the exact crossover frequency, a magno-
cellular deﬁcit will always bemost pronounced at low spatial
frequencies. Because only one reviewed study reported a
low-frequency predominance, we concluded that the spatial
tuning of contrast sensitivity loss in schizophrenia is gener-
ally not consistent with magnocellular deﬁcits. This conclu-
sion is independent of the exact crossover frequency.
Keri (2008) further suggests using chromatic stimulus
properties to separate magnocellular and parvocellular
visual pathways. Schechter et al. (2005) found statistically
1184 Reply / Vision Research 48 (2008) 1183–1185signiﬁcant reductions in N1 amplitude (an electrophysiolog-
ical measure) to isoluminant chromatic stimulation in
schizophrenic subjects. This again seems inconsistent with
the existence of a magnocellular deﬁcit.
Also, with regard to using isoluminant color to separate
parvo- and magnocellular responses, some caution is re-
quired since parvocellular neurons respond to both color
and luminance. In addition, color and luminance appear
to be segregated at the cortical level. It is therefore impor-
tant to distinguish between responses to color and lumi-
nance stimuli on the one hand, and parvo- and
magnocellular responses on the other (Skottun & Skoyles,
in press-a). Furthermore, in the case of visual functions
which depend on contrast, it is important that the color
and luminance stimuli are equated for contrast. This may
be problematic since ‘‘color contrast” is not equivalent to
‘‘luminance contrast”.
Issue 2. Keri (2008) writes ‘‘[t]o more parsimoniously
isolate magnocellular and parvocellular pathways, we used
a spatial oﬀset detection (vernier) task . . .”. The use of Ver-
nier acuity to assess magnocellular sensitivity is problem-
atic for a variety of reasons. It is our intention to
comment on this topic in a separate report. Irrespective,
the issue of Vernier acuity does not alter the fact that con-
trast sensitivity data provide little evidence for magnocellu-
lar deﬁcits in schizophrenia.
Issue 3. Keri (2008) writes that we ‘‘. . . did not take
into consideration the diﬀerent characteristics of typical
. . . and atypical . . . antipsychotics”. Keri cites the work
of Chen et al. (2003) which compared temporal contrast
sensitivity for patients receiving typical and atypical med-
ication to controls. When we re-plotted their data we
found (see Fig. 3g of Skottun & Skoyles, 2007a) the
main diﬀerence between the typical and atypical medica-
tion was that the group receiving typical medication
showed reduced sensitivity near 5 Hz. How to relate this
speciﬁcally to the magnocellular system is not clear.
However, there was, in neither patient group, evidence
for suppressed sensitivity at high temporal frequencies
as would be predicted from a magnocellular deﬁcit. Also,
O’Donnell et al. (2006) studied temporal contrast sensi-
tivity in unmedicated schizophrenic patients. These pa-
tients showed generally reduced sensitivity at all
temporal frequencies. These results, obviously, cannot
be attributed to medication of any kind. (A general
reduction in temporal contrast sensitivity is not consis-
tent with a magnocellular deﬁcit.) In our review we
did, moreover, discuss the potential eﬀects of medication
on the contrast sensitivity data. Our conclusion was that
it is diﬃcult to make a link between medication and con-
trast sensitivity in the studies we discussed. We still think
this is the case. Furthermore, the issue of typical versus
atypical medication does not alter the fact that the exist-
ing contrast sensitivity data oﬀer very little support for
the existence of magnocellular deﬁcits in schizophrenia.
Issue 4.Keri (2008) writes: ‘‘. . . when arguing against the
overactivity of magnocellular pathways, Skottun andSkoyles did not take into consideration the possibility that
magnocellular dysfunctions may change during the course
of the illness”. First, the main point of our comment about
an overactive magnocellular system concerns the ﬁnding of
reduced sensitivity present in several of the contrast sensi-
tivity studies we reviewed. This appears to conﬂict with
the suggestion, made on the basis of masking studies, that
schizophrenic individuals have an overly active magnocel-
lular system. However, as we noted, this apparent conﬂict
vanishes if the notion that the abnormalities reﬂect magno-
cellular deﬁcits is relinquished. Second, with regard to the
notion that ‘‘magnocellular dysfunction may change dur-
ing the course of the illness”, this, although possible, does
not detract from the fact that the published data on con-
trast sensitivity in schizophrenia provide little evidence
for a link between magnocellular deﬁcits and
schizophrenia.
In addition to these four points, Keri (2008) writes:
‘‘The severity of visual illusions experienced by the prodro-
mal participants positively correlate with the magnocellular
sensitivity values”. In support of this Keri references a
study (Keri & Benedek, 2007) involving persons who were
at high risk for psychosis. This would however imply that
magnocellular abnormalities are not speciﬁcally linked to
the diagnosis of schizophrenia. Also, there is evidence to
indicate that the risk for schizophrenia is not related to
magnocellular dysfunction (Badcock, 1993).
The general comment of Keri (2008) was that our focus
is too narrow, i.e. that ‘‘it is not suﬃcient to focus on lumi-
nance contrast sensitivity data”. It seems, however, that
even if substantial evidence existed for magnocellular deﬁ-
cits from tests other than contrast sensitivity, one would
still have to account for the fact that tests of contrast sen-
sitivity—which is the most direct psychophysical test of
magnocellular sensitivity (Skottun, 2000)—have not pro-
vided compelling evidence for magnocellular deﬁcits in
connection with schizophrenia.
In conclusion, none of Keri’s comments require that we
revise or modify our conclusion that the evidence from
contrast sensitivity largely fails to oﬀer support for the exis-
tence of magnocellular deﬁcits in schizophrenia.References
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